BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:46 PM
 | 
Apr 24, 2008
 |  BC Extra  |  Company News

FDA approves Relistor

FDA approved an NDA for subcutaneous Relistor methylnaltrexone from Progenics (NASDAQ:PGNX) and Wyeth (NYSE:WYE) to treat opioid-induced...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >